Clinical trials
Completed Metabolic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
138 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 7 |
| 2009 | 8 |
| 2010 | 10 |
| 2011 | 9 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 5 |
| 2016 | 10 |
| 2017 | 5 |
| 2018 | 11 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 9 |
| 2022 | 8 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 138 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 7 |
| Eli Lilly and Company | 7 |
| Massachusetts General Hospital | 5 |
| Pfizer | 4 |
| Regeneron Pharmaceuticals | 4 |
| 89bio, Inc. | 3 |
| AdventHealth Translational Research Institute | 3 |
| Kastle Therapeutics, LLC | 3 |
| Ultragenyx Pharmaceutical Inc | 3 |
| University of Michigan | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 138 |
| Diabetes Mellitus | 38 |
| Diabetes Mellitus, Type 2 | 30 |
| Glucose Metabolism Disorders | 30 |
| Endocrine System Diseases | 25 |
| Obesity | 25 |
| Lipid Metabolism Disorders | 18 |
| Dyslipidemias | 17 |
| Insulin Resistance | 17 |
| Genetic Diseases, Inborn | 14 |
Trials
Showing 1 to 25 of 138. Each trial links to its page on Pharma Observatory.
38 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.